Munich, Germany

Reinhold Kerb

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Epidauros Biotechnologie Ag. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhold Kerb. Retrieved from https://idiyas.com/inventor/reinhold-kerb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reinhold Kerb: Innovator in Genetic Testing

Introduction

Reinhold Kerb is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in genetic testing. His work focuses on methods that enhance the detection of genetic mutations, which can have profound implications for patient care.

Latest Patents

Reinhold Kerb holds a patent for a "Method for determining the presence of at least one allele of a GSTT1 deletion mutant." This innovative method involves a PCR assay designed to detect the presence of at least one GST1*0 allele. The process utilizes two primers, one from the sequence upstream of the deletion area and the other from the sequence downstream. The production of the corresponding DNA fragment in the PCR is then verified. This method is particularly useful for testing patients to determine their susceptibility to toxins or their sensitivity to certain therapeutic agents.

Career Highlights

Throughout his career, Reinhold has been associated with Epidauros Biotechnologie AG, where he has contributed to various projects aimed at advancing genetic testing technologies. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Reinhold Kerb has worked alongside esteemed colleagues such as Raimund Sprenger and Robert Schlagenhaufer. Their collaborative efforts have furthered research and development in the biotechnology sector.

Conclusion

Reinhold Kerb's innovative work in genetic testing exemplifies the impact of biotechnology on healthcare. His contributions continue to influence the way genetic mutations are detected and understood, ultimately benefiting patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…